Citation Impact
Citing Papers
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
2012 Standout
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
2009
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
2008
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq
2015 StandoutScience
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
2018 Science
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Evolution of new nonantibody proteins via iterative somatic hypermutation
2004 StandoutNobel
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
2009
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Structure of the human TRPM4 ion channel in a lipid nanodisc
2017 StandoutScienceNobel
AID Enzyme-Induced Hypermutation in an Actively Transcribed Gene in Fibroblasts
2002 StandoutScienceNobel
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
2014 Standout
Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis
2008
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene
1997
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
2008
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Gene Sets Identified with Oncogene Cooperativity Analysis Regulate In Vivo Growth and Survival of Leukemia Stem Cells
2012
Discoveries in structure and physiology of mechanically activated ion channels
2020 StandoutNatureNobel
A view on drug resistance in cancer
2019 StandoutNature
Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices
2005
Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis
2001
Viridans Group Streptococcal Infections Among Children With Cancer and the Importance of Emerging Antibiotic Resistance
2006
Impact of normalization on miRNA microarray expression profiling
2009
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
2009
Targeting microRNAs in cancer: rationale, strategies and challenges
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Cytogenetics in acute leukemia
2003
Ionizing radiation‐induced long‐term expression of senescence markers in mice is independent of p53 and immune status
2010
Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome
2007
Antibiotic prophylaxis in neutropenic patients
2006
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 Nature
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
2010
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Antitumour actions of interferons: implications for cancer therapy
2016
TdT-Accessible Breaks Are Scattered over the Immunoglobulin V Domain in a Constitutively Hypermutating B Cell Line
1998
Electron cryo-microscopy structure of the mechanotransduction channel NOMPC
2017 Nature
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
2009
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
2005
Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors
1996
Immunity, Inflammation, and Cancer
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
2009
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Treatment of Relapsed/Refractory Multiple Myeloma
2009
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
Pathogenesis and treatment of renal failure in multiple myeloma
2008
Apoptotic Cell Death in Chronic Lymphocytic Leukemia
1993
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
The role of senescent cells in ageing
2014 StandoutNature
Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation
2013
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Treatment of Multiple Myeloma: A Comprehensive Review
2009
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution
2008
Comprehensive Integration of Single-Cell Data
2019 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Multiple Stat complexes interact at the interferon regulatory factor-1 interferon-γ activation sequence in prolactin-stimulated Nb2 T cells
1996
AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching
2001 StandoutNatureNobel
Chronic Lymphocytic Leukemia
2005
Fever of Unknown Origin in Febrile Leukopenia
2007
A cell line model for the differentiation of human dendritic cells
2005
Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma
2012
Using GOstats to test gene lists for GO term association
2006 Standout
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins
2003
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
2012
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
2012
Prevention and Treatment of Cancer-Related Infections
2012
Independent filtering increases detection power for high-throughput experiments
2010
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
2010
Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients
2010
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
A feedback circuit involving let-7-family miRNAs and DAF-12 integrates environmental signals and developmental timing in Caenorhabditis elegans
2009 StandoutNobel
Innate Immune Recognition of Cancer
2015
Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.
1999
MicroRNA 29b functions in acute myeloid leukemia
2009
Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents
2008
Multiple Myeloma
2010
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
2005 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1
2002
Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch
2004
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
1998
High expression of cereblon (CRBN ) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone
2013
Improved scoring of functional groups from gene expression data by decorrelating GO graph structure
2006 Standout
Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia
1999
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells
2015
Synergistic effect of prolactin on IFN-γ-mediated growth arrest in human monoblastic cells: correlation with the up-regulation of IFN-γ receptor gene expression
1996
Neoantigens in cancer immunotherapy
2015 StandoutScience
Biallelic inactivation of hMLH 1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
1998 StandoutNobel
Multiple Myeloma
2011 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Regulation of T-cell receptor gene expression in human T-cell development.
1985 StandoutNobel
Phenotypic heterogeneity and cellular origins of T cell malignancies
1981
Structural insights into TRPM8 inhibition and desensitization
2019 StandoutScienceNobel
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
2009
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Works of Robin Foà being referenced
Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation
2005
Multiparameter studies in lymphoid leukemias.
1979
Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic Leukemia
1991
Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles
2009
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics
2013
Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells
1995
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis
2008
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma
2012
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
2005
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia
2001
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene
2011
Interleukin-2 for the Treatment of Advanced Acute Myelogenous Leukemia Patients with Limited Disease: Updated Experience with 20 Cases
1996
Chronic myeloid leukemia cells resistant to interferon-α lack STAT1 expression
2000
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
2007
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
2000
A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
1994
CD34+ Acute Myeloid and Lymphoid Leukemic Blasts Can Be Induced to Differentiate Into Dendritic Cells
1999
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
2011
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia
2014
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
2008
Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer.
1996
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
2010
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements
2003
Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia
2007
Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion
1996
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
2003
Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network
2007
ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
2008
Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors
2004
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases
2009
Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia
2004